Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899866-18-000114)

Filing Details

Accession Number:: 0000899866-18-000114
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-12 17:23:37
Reporting Period:: 2018-07-10

Accepted Time:: 2018-07-12 17:23:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899866	Alexion Pharmaceuticals Inc.	ALXN	Pharmaceutical Preparations (2834)	133648318

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1409601	J Paul Clancy	C/O Alexion Pharmaceuticals, Inc. 121 Seaport Blvd Boston MA 02210	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $.0001 Per Share	Disposition	2018-07-10	5,241	$131.11	93,309	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.